Stockreport

SciSparc Secures Strategic Advantage with Grant of European Patent

SciSparc Ltd.  (SPRC) 
PDF TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing [Read more]